NL7711916A - Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden. - Google Patents

Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.

Info

Publication number
NL7711916A
NL7711916A NL7711916A NL7711916A NL7711916A NL 7711916 A NL7711916 A NL 7711916A NL 7711916 A NL7711916 A NL 7711916A NL 7711916 A NL7711916 A NL 7711916A NL 7711916 A NL7711916 A NL 7711916A
Authority
NL
Netherlands
Prior art keywords
steroids
pharmaceutical preparations
highly concentrated
preparing highly
concentrated pharmaceutical
Prior art date
Application number
NL7711916A
Other languages
English (en)
Dutch (nl)
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Priority to NL7711916A priority Critical patent/NL7711916A/xx
Priority to DE7878200249T priority patent/DE2861320D1/de
Priority to EP78200249A priority patent/EP0001851B1/en
Priority to US05/953,877 priority patent/US4212863A/en
Priority to FI783249A priority patent/FI67298C/fi
Priority to JP13248878A priority patent/JPS5480404A/ja
Priority to DK480178A priority patent/DK152721C/da
Priority to NZ188755A priority patent/NZ188755A/xx
Priority to AU41158/78A priority patent/AU523752B2/en
Priority to CH401479A priority patent/CH643738A5/de
Publication of NL7711916A publication Critical patent/NL7711916A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
NL7711916A 1977-10-29 1977-10-29 Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden. NL7711916A (nl)

Priority Applications (10)

Application Number Priority Date Filing Date Title
NL7711916A NL7711916A (nl) 1977-10-29 1977-10-29 Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
DE7878200249T DE2861320D1 (en) 1977-10-29 1978-10-18 Highly concentrated pharmaceutical formulations of steroids and processes for their preparation
EP78200249A EP0001851B1 (en) 1977-10-29 1978-10-18 Highly concentrated pharmaceutical formulations of steroids and processes for their preparation
US05/953,877 US4212863A (en) 1977-10-29 1978-10-23 Highly concentrated pharmaceutical formulations of steroids and processes for their preparation
FI783249A FI67298C (fi) 1977-10-29 1978-10-25 Foerfarande foer framstaellning av terapeutiskt anvaendbar loesning av steroid
JP13248878A JPS5480404A (en) 1977-10-29 1978-10-27 High concentrated pharmaceutical preparation of steroid and production thereof
DK480178A DK152721C (da) 1977-10-29 1978-10-27 Fremgangsmaade til fremstilling af et kraftigt koncentreret, flydende farmaceutisk praeparat af et steroid
NZ188755A NZ188755A (en) 1977-10-29 1978-10-27 Formulations of steroids of estrane,androstane and 19-nor-pregnane series and tocol or a derivative thereof
AU41158/78A AU523752B2 (en) 1977-10-29 1978-10-30 Concentrated liquid formulation of steroid and tocol
CH401479A CH643738A5 (en) 1977-10-29 1979-04-27 Highly concentrated pharmaceutical steroid products

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7711916A NL7711916A (nl) 1977-10-29 1977-10-29 Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.

Publications (1)

Publication Number Publication Date
NL7711916A true NL7711916A (nl) 1979-05-02

Family

ID=19829436

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7711916A NL7711916A (nl) 1977-10-29 1977-10-29 Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.

Country Status (10)

Country Link
US (1) US4212863A (xx)
EP (1) EP0001851B1 (xx)
JP (1) JPS5480404A (xx)
AU (1) AU523752B2 (xx)
CH (1) CH643738A5 (xx)
DE (1) DE2861320D1 (xx)
DK (1) DK152721C (xx)
FI (1) FI67298C (xx)
NL (1) NL7711916A (xx)
NZ (1) NZ188755A (xx)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2164286T3 (es) * 1993-04-20 2002-02-16 Hexal Ag Emplasto con sustancias activas.
CN1102095A (zh) * 1993-10-30 1995-05-03 浙江医科大学 长效雄激素类制剂——十一酸睾丸注射液
GB9409778D0 (en) 1994-05-16 1994-07-06 Dumex Ltd As Compositions
US5980945A (en) * 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
US6458373B1 (en) 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US7030155B2 (en) 1998-06-05 2006-04-18 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB0000313D0 (en) * 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
US6703398B2 (en) * 2001-11-26 2004-03-09 Oliver Yoa-Pu Hu Orally administered analgesic compositions containing nalbuphine
WO2003061566A2 (en) * 2002-01-24 2003-07-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Anti-cancer combination and use thereof
JO2505B1 (en) 2003-03-14 2009-10-05 باير شيرنغ فارما اكتنجيسيلشافت Pharmacy methods and formulations for obtaining acceptable serum testosterone levels
GB0807605D0 (en) 2008-04-28 2008-06-04 Diurnal Ltd Lipid composition

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3025311A (en) * 1955-07-01 1962-03-13 Upjohn Co Hydrocortisone 21-beta beta-dimethyl glutarate and derivatives thereof
US2791609A (en) * 1956-09-27 1957-05-07 Murray A Kaplan Tetracycline metallo-phosphate complexes and method preparation
US3085939A (en) * 1959-05-11 1963-04-16 Upjohn Co Oil-in-water emulsion for oral administration, and process for preparation
US3149037A (en) * 1962-09-07 1964-09-15 Hoffmann La Roche Vitamin compositions
DE1492034A1 (de) 1965-05-18 1969-02-20 Merck Ag E Verfahren zur Herstellung fester haltbarer Zubereitungen von empfindlichen,in Wasser schwer loeslichen Wirkstoffen,vorzugsweise Arzneimitteln
JPS4916422B1 (xx) * 1966-05-09 1974-04-22
US3636195A (en) * 1968-09-10 1972-01-18 Borden Inc Growth stimulating animal feeds
DE2240187A1 (de) * 1972-08-16 1974-02-21 Jereb Franz Dr Albin Salbe
GB1453239A (en) * 1974-04-30 1976-10-20 Ahrens G W Vitamin e active product and a method of preparing same

Also Published As

Publication number Publication date
AU523752B2 (en) 1982-08-12
AU4115878A (en) 1980-05-08
DE2861320D1 (en) 1982-01-14
FI67298B (fi) 1984-11-30
DK152721C (da) 1988-09-26
DK480178A (da) 1979-04-30
US4212863A (en) 1980-07-15
FI783249A (fi) 1979-04-30
JPS5480404A (en) 1979-06-27
NZ188755A (en) 1981-02-11
FI67298C (fi) 1985-03-11
EP0001851B1 (en) 1981-11-11
CH643738A5 (en) 1984-06-29
DK152721B (da) 1988-05-02
EP0001851A1 (en) 1979-05-16
JPS6341887B2 (xx) 1988-08-19

Similar Documents

Publication Publication Date Title
NL7703729A (nl) Werkwijze voor de bereiding van pour-on-prepa- raten van anthelmintica.
NL7609414A (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van 1-sulfonylbenzimidazoolderivaten.
NL7613791A (nl) Werkwijze voor de bereiding van polyhalogeen- steroiden.
NL7611295A (nl) Werkwijze ter bereiding van nieuwe galenische preparaten.
NL7601514A (nl) Werkwijze ter bereiding van enolderivaten.
NL7803623A (nl) N-acetyl-dehydro-thienamycine en zouten daarvan; werk- wijze ter bereiding van deze verbindingen en farmaceu- tische preparaten.
NL7503055A (nl) Werkwijze ter bereiding van therapeutische preparaten.
NL7708943A (nl) Werkwijze ter bereiding van onverzadigde derivaten van 7-acylamido-3-cefem-4-carbonzuur.
NL7711916A (nl) Werkwijze ter bereiding van sterk geconcen- treerde farmaceutische preparaten van steroiden.
NL7606612A (nl) Werkwijze ter bereiding van nieuwe farmaceutische preparaten.
NL7609411A (nl) Werkwijze ter bereiding van farmaceutische preparaten en werkwijze ter bereiding van nieuwe thiazolinylbenzimidazoolderivaten.
NL7604395A (nl) Werkwijze ter bereiding van uitvlokmiddelen.
NL7606906A (nl) Werkwijze voor de bereiding van thymol.
NL7606966A (nl) Werkwijze ter bereiding van fenothiazinederivaten.
NL7612239A (nl) Werkwijze ter bereiding van derivaten van dauno- rubicine alsmede preparaten die deze derivaten bevatten.
NL187533C (nl) Werkwijze ter bereiding van 6alfa-halogeenpregnaanderivaten, alsmede tussenprodukten van deze werkwijze.
NL7610059A (nl) Werkwijze voor de bereiding van 4-oxo-4h-benzo- pyranderivaten.
NL7610607A (nl) Werkwijze voor de bereiding van rodenticide- preparaten.
NL7610057A (nl) Werkwijze voor de bereiding van farmaceutische preparaten.
NL7603449A (nl) Werkwijze voor de bereiding van (alpha)-fenylpropion- zuren.
NL7608796A (nl) Werkwijze voor de bereiding van oxyranderivaten.
NL7604330A (nl) Werkwijze voor de bereiding van 8-azaprostaan- zuurderivaten.
NL7607693A (nl) Werkwijze voor de bereiding van tegen ontste- kingen werkende en bloeddrukverlagende prepara- ten.
NL7714205A (nl) Werkwijze ter bereiding van 5-fluoruracilderi- vaten en farmaceutische preparaten die deze derivaten bevatten.
NL7605032A (nl) Werkwijze ter bereiding van nieuwe cefemverbindingen en werkwijze ter bereiding van farmaceutische pre- paraten.

Legal Events

Date Code Title Description
BV The patent application has lapsed